Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

HER2-positive Early Breast Cancer × Carboplatin × 1 year × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Carcinoma, Non-Small-Cell Lung 199 Lung Neoplasms 71 Triple Negative Breast Neoplasms 57 Breast Neoplasms 55 Ovarian Neoplasms 52 Squamous Cell Carcinoma of Head and Neck 46 Small Cell Lung Carcinoma 36 Fallopian Tube Neoplasms 36 Endometrial Neoplasms 30 Neoplasms 29 Parkinson Disease 4, Autosomal Dominant Lewy Body 24 Neoplasm Metastasis 21 Prostatic Neoplasms 20 Head and Neck Neoplasms 20 Colorectal Neoplasms 18 Uterine Cervical Neoplasms 15 Urinary Bladder Neoplasms 14 Esophageal Neoplasms 14 Carcinoma 14 Carcinoma, Squamous Cell 13 Oropharyngeal Neoplasms 12 Esophageal Squamous Cell Carcinoma 12 Carcinoma, Transitional Cell 12 Brain Neoplasms 11 Pancreatic Neoplasms 10 Stomach Neoplasms 9 Lung Diseases 9 Respiratory Tract Neoplasms 8 Mouth Neoplasms 8 Laryngeal Neoplasms 8

Interventions

pertuzumab 2 Trastuzumab 2 pyrotinib 1 Taxes 1 Surgical Procedures, Operative 1 Doxorubicin 1 Docetaxel 1 Cyclophosphamide 1 Carboplatin 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT07340398 2026-01-21

TAYLOR

Second Affiliated Hospital, School of Medicine, Zhejiang University

Phase 2 Recruiting

HER2-positive Early Breast Cancer

Data powered by HemOnc (CC BY 4.0) Colophon ⚡